Takeoff41 launches feasibility study at Stanford NICU

Takeoff41 initiated a clinical feasibility study (NCT07414576) at Stanford University's neonatal intensive care unit, marking the first time TPN2.0 has been deployed in a live clinical environment. The study plans to enroll 260 infants.

The study evaluates how TPN2.0 fits real prescribing workflow, from chart import through pharmacist verification, and gathers the evidence base for wider deployment.